Subcutaneous risankizumab (Skyrizi) induction therapy significantly improved clinical remission and endoscopic response rates ...

Among 7,100 pregnant migraineurs, anti-CGRP monoclonal antibody exposure was associated with a 42% higher risk of spontaneous ...

Kai Trump, President Trump's granddaughter and a freshman on the University of Miami golf team, revealed that she had surgery ...

The FDA announced approval of apraclonidine ophthalmic solution 0.125% (Brytly) as an over-the-counter treatment for eye ...

Several key developments have contributed to improved survival and other outcomes in adults with SCD. Noting that she has ...

The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday.

Ten medical specialties now earn over $600,000 a year. The one at the top clears 800k, and a handful of them just got the ...

Zydus Lifesciences and Formycon AG announced FDA acceptance of a biologics license application for FYB206, a biosimilar to ...

True or False: A population-based study showed that benzodiazepine exposure early in pregnancy increased risks of congenital ...

Late last month, the Trump administration announced that it had cut 760,000 people from the Affordable Care Act (ACA) rolls, ...

Christa Pike's failed execution brought attention to physician participation in lethal injections, with some asserting that ...

As the year comes to a close, the nation's physician associates (PAs) are looking forward to pursuing their state legislative agenda for 2027, including easing scope-of-practice restrictions.